• Korean
  • Chinese
Cover Image

Future Horizons and Growth Strategies in the UK Sexually-Transmitted Diseases (STD) Diagnostic Testing Market 2014: Supplier Shares and Country Forecasts

About This Report

This new 280-page report from Venture Planning Group presents detailed analysis of the UK STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis.  The report provides test volume and sales projections for Hospitals, Commercial and Public Health Labs.    

In addition to market share and sales forecasts, the report:

-  Examines market applications of Molecular Diagnostics,  
   Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;

-  Reviews features and operating characteristics of major analyzers used
   for STD testing;

-  Profiles key suppliers and potential market entrants developing innovative
   technologies and products; and

-  Analyzes emerging opportunities, alternative market penetration strategies,
   market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.

In addition to primary sources of information, a comprehensive review of
the most recent technical and business publications, manufacturer product
and financial literature, as well as Venture Planning Group’s proprietary data files was conducted.
 
Contains 280 pages and 16 tables

Table of Contents

I. Introduction

II. Worldwide Market and Technology Overview

  • A. Major Infectious Disease Tests
    • 1. Chancroid
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 2. Chlamydia
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 3. Gonorrhea
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 4. Herpes Simplex Virus
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • Human Herpes Virus-6 (HHV-6)
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 5. Papillomavirus (HPV)
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 6. Syphilis
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
  • B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
  • C. Emerging Diagnostic Technologies
    • 1. Molecular Diagnostics
    • 2. Monoclonal Antibodies
    • 3. Immunoassays
    • 4. Differential Light Scattering
    • 5. Information Technology
    • 6. Artificial Intelligence
    • 7. Liposomes
    • 8. Flow Cytometry
    • 9. Chromatography
    • 10. Diagnostic Imaging
    • 11. Gel Microdroplets
    • 12. Other

VIII. UK: Market Size, Growth and Major Suppliers' Sales and Market Shares

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

Competitive Assessments

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Enzo Biochem
  • Fujirebio
  • Gen-Probe
  • Hologic
  • ID Biomedical
  • Innogenetics/Solvay
  • Kreatech
  • Life Technology
  • Lonza
  • Nanogen/Elitech
  • Novartis Diagnostics
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • Takara Bio
  • Thermo Fisher
  • Wallac
  • Wako

List of Tables

  • Major Companies Developing or Marketing Chlamydia Tests
  • Major Companies Developing or Marketing Gonorrhea Tests
  • Major Companies Developing or Marketing Herpes Tests
  • Major Companies Developing or Marketing Pap Smear/HPV Tests
  • Major Companies Developing or Marketing Syphilis Tests
  • U.K. Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K. Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K. Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K. Gonorrhea Testing Market Diagnostics Sales by Major Supplier
  • U.K. Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K. Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K. Herpes Testing Market Diagnostics Sales by Major Supplier
  • U.K. PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K. Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K. Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K. Syphilis Testing Market Diagnostics Sales by Major Supplier
Show More
Pricing
Get Notified
Email me when related reports are published